Skip to main content
. Author manuscript; available in PMC: 2020 Oct 1.
Published in final edited form as: J Pain. 2019 Apr 18;20(10):1218–1235. doi: 10.1016/j.jpain.2019.04.005

Table 7.

Abuse Measures in Opioid Studies in Drug Abusers and Non-Drug Abusers

Abuse Measure Versus Placebo*
Opioid, Oral Route N Drug Liking- Disliking Take Drug Again Strength of Drug Effect Study
Drug abusers
 Morphine
  25 mg 12 8 6 35 Zacny 2005
 Oxycodone
  15 mg 9 21 35 43 Comer 2010
  30 mg 9 19 33 50 Comer 2010
 Hydromorphone
  4 mg 8 29 19 Duke 2011
  8 mg 8 44 32 Duke 2011
 Tramadol
  50 mg 22 3 5 5 Zacny 2005
  100 mg 22 10 9 20 Zacny 2005
  50 mg 8 1 0 Duke 2011
  100 mg 8 6 4 Duke 2011
  200 mg 8 15 19 Duke 2011
  400 mg 8 24 19 Duke 2011
Non-drug abusers
 Morphine
  30 mg 20 12 12 28 Zacny 2008
  40 mg 18 12 12 33 Zacny 2003
 Oxycodone
  10 mg 18 13 15 30 Zacny 2003
  15 mg 9 19 18 45 Comer 2010
  20 mg 18 20 21 48 Zacny 2003
  20 mg 20 16 17 53 Zacny 2008
  30 mg 9 18 15 53 Comer 2010
  30 mg 18 21 20 58 Zacny 2003
 Hydrocodone
  15 mg 20 4 4 33 Zacny 2009
  30 mg 20 8 6 50 Zacny 2009
 Tramadol
  50 mg 43 -1 -2 20 This study
 Desmetramadol
  20 mg 43 -2 -6 17 This study
*

Difference between peak drug and placebo value, normalized to 100 point scale where required. Data collated from Comer 2010,6 Duke 2011,19 Zacny 2003,89 Zacny 2005,88 Zacny 2008,91 and Zacny 2009.90

Statistically significant compared with placebo.

Acetaminophen combination.